Expertise in
1
conditions

Dr. Michal Rose

Hematology
Va Connecticut Hcs-West Haven
950 Campbell Ave, 
West Haven, CT 
Expertise in
1
conditions
Va Connecticut Hcs-West Haven
950 Campbell Ave, 
West Haven, CT 

Overview

Michal Rose is a Hematologist in West Haven, Connecticut. Dr. Rose is highly rated in 1 condition, according to our data. Her top areas of expertise are Urticaria Pigmentosa, Chronic Myelogenous Leukemia (CML), Lung Cancer, and Systemic Mastocytosis.

Her clinical research consists of co-authoring 33 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in CT

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Va Connecticut Hcs-West Haven
950 Campbell Ave, West Haven, CT 06516

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Completed
Publish Date: February 03, 2026
Intervention Type: Other
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drugs: RRx-001, Cisplatin, Etoposide, Carboplatin, Irinotecan, Vinorelbine, Doxil, Gemcitabine, Taxane, Paclitaxel, Nab-Paclitaxel, Pemetrexed
Study Phase: Phase 2
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug, Procedure
Study Drugs: Fluorouracil, Gemcitabine hydrochloride, Irinotecan hydrochloride, Oxaliplatin, Paclitaxel albumin-stabilized nanoparticle formulation
Study Phase: Phase 2
View 3 Less Clinical Trials

33 Total Publications

A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline.
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline.
Journal: Frontiers in neuroscience
Published: July 31, 2024
Similar Doctors
Expertise in
23
conditions
Dr. Amer Zeidan
Hematology
Expertise in
23
conditions
Dr. Amer Zeidan
Hematology

Yale New Haven Hospital

20 York St, 
New Haven, CT 
 (1.8 miles away)
203-200-4363
Languages Spoken:
English
See accepted insurances

Amer Zeidan is a Hematologist in New Haven, Connecticut. Dr. Zeidan is highly rated in 23 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
29
conditions
Dr. Nikolai Podoltsev
Hematology
Expertise in
29
conditions
Dr. Nikolai Podoltsev
Hematology

Yale New Haven Hospital

20 York St, 
New Haven, CT 
 (1.8 miles away)
203-200-4363
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nikolai Podoltsev is a Hematologist in New Haven, Connecticut. Dr. Podoltsev is highly rated in 29 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
14
conditions
Dr. Mario Sznol
Hematology | Oncology
Expertise in
14
conditions
Dr. Mario Sznol
Hematology | Oncology

Yale University

20 York St, 
New Haven, CT 
 (1.8 miles away)
203-688-2433
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Mario Sznol is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Sznol has been practicing medicine for over 44 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, and Metastatic Uveal Melanoma.

Frequently Asked Questions about Dr. Michal Rose

How do I make an appointment with Dr. Michal Rose?

You can book an appointment with Dr. Michal Rose by calling their office at 203-248-2508. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michal Rose a top-rated expert for Urticaria Pigmentosa?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michal Rose is classified as an Advanced expert for Urticaria Pigmentosa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michal Rose specialize in?

While Dr. Michal Rose is a Hematology, they have specific expertise in Urticaria Pigmentosa, Chronic Myelogenous Leukemia (CML), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Michal Rose participate in research or clinical trials?

Yes. Dr. Michal Rose has published 33 articles and abstracts on conditions like Urticaria Pigmentosa. You can view a list of Dr. Michal Rose's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michal Rose accept my insurance?

Dr. Michal Rose accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 203-248-2508 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rose's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile